long intergenic non-protein coding RNA 2028Genealiases: []
Q-omics provides the consensus-scored LINC02028 profile across patient tissues and cancer cell-line models. LINC02028 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in LGG. Among the 18 cancer types available for tumor–normal comparison, LINC02028 is differentially expressed in 11, with the highest sampling consensus in THCA. Additionally, LINC02028 RNA expression shows 14,175 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight LGG, THCA, and TGCT as cancer lineages where LINC02028 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02028 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02028 survival associations across molecular data types. LINC02028 RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02028 RNA expression–survival associations across cancer types. High LINC02028 expression shows unfavorable associations in LGG, ACC, SKCM and GBM, but favorable associations in UCS and READ. The LGG Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LGG as the clearest survival context for LINC02028 RNA expression.
This table summarizes LINC02028 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02028. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02028 shows lower tumor expression in THCA, KIRP, HNSC, KIRC and CHOL and higher tumor expression in KICH. The THCA box plot shows higher LINC02028 RNA expression in normal versus tumor tissue (log2 FC = −1.299, t-test p < 0.001).
This table shows molecular features associated with LINC02028 in patient tissues and cancer cell lines. In patient samples, LINC02028 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
